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Sensing biological agents at the genomic level, while enhancing the response time for biodetection over commonly used, optics-
based techniques such as nucleic acid microarrays or enzyme-linked immunosorbent assays (ELISAs), is an important criterion
for new biosensors. Here, we describe the successful detection of a 35-base, single-strand nucleic acid target by Hall-based
magnetic transduction as a mimic for pathogenic DNA target detection. The detection platform has low background, large signal
ampliﬁcationfollowingtargetbindingandcandiscriminateasingle,350nmsuperparamagneticbeadlabeledwithDNA.Detection
of the target sequence was demonstrated at 364pM (<2 target DNA strands per bead) target DNA in the presence of 36µM
nontarget (noncomplementary) DNA (<10ppm target DNA) using optical microscopy detection on a GaAs Hall mimic. The use
of Hall magnetometers as magnetic transduction biosensors holds promise for multiplexing applications that can greatly improve
point-of-care (POC) diagnostics and subsequent medical care.
1.Introduction
The ability to detect and discriminate speciﬁc nucleic acid
sequences within a biological mixture has implications for
genome sequencing and single-nucleotide polymorphism
(SNP) detection, biowarfare target detection, and the devel-
opment of an eﬃcient point-of-care (POC) device for path-
ogenidentiﬁcation[1–6].Throughtheintegrationofbiology
with nanotechnology, a detection platform utilizing mag-
netictransductioncancapitalizeonthehighbiologicalspeci-
ﬁcity of DNA base pairing, the scalability of nanotechnology,
the selectivity of self-assembled monolayer technology, and
the sensitivity of magnetic transduction [7, 8]. Coupling the
extreme sensitivity of Hall-based magnetic detection, which
operates over a wide magnetic ﬁeld and temperature range,
with the versatility and speciﬁcity of DNA base pairing can
allow the realization of a new biological detection strategy
that will improve POC diagnostics and subsequent medical
treatment.
In this paper the detection of a 35-base pair DNA
target sequence is demonstrated at the single-bead level on
a Hall magnetometer biosensor. The biosensor is able to
identify a single-bead bound to target DNA (35 bases) and
is amenable to the discrimination of DNA at the 364pM
concentration in a background of 36µM noncomplementary
DNA (<10ppm). The detection strategy utilizes three-strand
DNA annealing to colocalize a superparamagnetic (SPM)
bead labeled probe strand, a label-free target strand, and a
receptor strand at the surface of the Hall device. Localization
of the SPM bead on the surface of the Hall cross’ active area
through annealing of all three DNA strands induces a voltage
change in the Hall junction due to a change in the local
magnetic ﬁeld. This study demonstrates the eﬀective use
of an optical/magnetic bead detection platform to measure
DNA at the picomolar (pM) level in the presence of µM
extraneous DNA. At the concentrations of DNA used in the
mimic, the device platform can be optimized for clinical2 Journal of Biomedicine and Biotechnology
translation.Developmentofsingle-nucleotidemismatchand
real-world pathogen samples are underway, but are beyond
the scope of the current study.
Many biosensors [9–24]s t i l ls u ﬀer from limitations in
stability, portability, sensitivity, and selectivity. Traditional
ELISA based sensor platforms are sensitive at the pM level
a n dr e q u i r e1 - 2d a y sf o rd e t e c t i o no fap r o t e i nt a r g e t .G M R
sensors, which are recent additions to the biosensor ﬁeld, can
detect at the pM or femtomolar (fM) levels if magnetically
assisted [25]. Optics-based sensors, whether colorimetric or
using FRET assays, allow detection at the attomolar (aM)
to nanomolar (nM) level. A novel approach utilized in
some optics-based biosensors is the use of three-strand DNA
annealing to produce an optical response that is directly
proportional to the annealing event. The use of three-
strand ssDNA annealing strategies has been investigated for
biological target detection for the last 15 years and has
been shown to increase overall sensitivity. Mirkin et al.
ﬁrst used the controlled assembly and aggregation of DNA
labeled Au nanoparticles in solution as a colorimetric sensor
[26]. Years later Taton et al. [14] utilized the tethering of
DNA-coated Au nanoparticles to DNA-coated surfaces using
an unlabeled target sequence for Ag-ampliﬁed colorimetric
detection with single-nucleotide mismatch sensitivity. The
technology has evolved further and been shown to detect
∼6 × 106 copies of genomic DNA using Ag-ampliﬁed
scanometric detection on a commercial platform [27, 28]. In
additiontotheassemblyofAunanoparticles,theassemblyof
Agnanoparticlesontosmoothmetalﬁlmsusingthree-strand
DNA assembly has been demonstrated for surface-enhanced
Raman spectroscopic detection of DNA sequences [29].
Optical methods focused on ﬂuorescence blotting assays
have reached aM sensitivities [23], while methods employing
energy transfer detection of the three-strand assembly allow
nMpathogenDNAdetection[20].Despitetheseapplications
of multisequence DNA assembly in the literature, the use of
three-strandassembliesformagneticdetectionhasonlybeen
suggested and remains underutilized [30].
Sensing technologies based on magnetic transduction,
whether Hall magnetometry or giant magnetoresistive
(GMR), circumvent many of the limitations of classical sen-
sor designs since they exhibit low sensitivity to the surround-
ing biological matrix of samples, can be mass produced,
and, if conﬁgured properly, can oﬀer dynamic detection
in a microfabricated scalable platform [31, 32]. Magnetic
transduction-based sensing technologies cover a wide range
of methods including GMR sensors through the use of spin
valves [25, 33–37]o rb e a da r r a yc o u n t e r s( B A R C s )[ 38, 39]
and Hall-based sensors [40–45]. Already, examples of GMR
devices have demonstrated detection of matrix-insensitive
protein assays at the fM level using a magnetic transduction-
based device [37] and aM level by adding additional
magnetic beads to amplify the signal [46]. The use of Hall
magnetometry for DNA biosensing could represent the next
generation for magnetic transduction-based devices, since a
Hall junction is a 4-point probe device (current, voltage),
scalable down to the nanoscale, can be mass produced using
standard lithographic and fabrication methods, displays a
linear response through a wide range of magnetic ﬁelds [47]
with minimal inﬂuence of temperature [48] (which varies to
optimize DNAannealing),andcanoperateathighfrequency
allowing for phase-sensitive detection of the transient ﬁelds
associated with SPM nanoscale beads. Hall biosensors may
thus oﬀer a useful alternative to exclusively ﬂuorescence-
based microarray technologies.
2.MaterialsandMethods
2.1. Substrate Fabrication and Passivation. The 1µm2 Hall
junction is fabricated into the surface of an epitaxially grown
heterostructure consisting of a GaAs substrate containing an
InAs quantum well core, and SiO2 (60nm) was sputtered
onto the device followed by a layer of Ti (5nm) and
deposition of 3µm gold pads (20nm thick) directly over
the protected Hall junction. Registry of the gold pad was
accomplished by photolithography using alignment markers
in the photomask. Mimic microarrays (3µm diameter circles
and 2µm × 4µm rectangular gold patterns) were fabricated
onto the  100  face of a single-crystal GaAs wafer. The
substrates were cleaned prior to use for 1min at low power
in oxygen plasma (Harrick Plasma PDC-001). The substrates
were rinsed with absolute ethanol for 1min and dried
under a constant stream of nitrogen gas, and the SiO2 sur-
facewaspassivatedby2-[methoxy(polyethyleneoxy)propyl]-
trimethoxysilane (Gelest) [49].
2.2. DNA Immobilization and Hybridization. Synthetic DNA
oligonucleotides were commercially synthesized (Midland
Certiﬁed Reagent Company). The two-strand DNA system
consisted of a 5  disulﬁde modiﬁed complementary receptor
sequence 5 -/RSSR/-GAC TAC TCT ATC GGC AGC TAA
GATTGTCACAGTCG-3 ,a5   disulﬁdemodiﬁednoncom-
plementary receptor sequence 5 -/RSSR/-CGA CTG TGA
CAA TCT TAG CTG CCG ATA GAG TAG TC-3 ,a n da
5  modiﬁed biotinylated probe sequence with an internal
ﬂuorescein dT 5 -/BIOTIN/-CGA C-/iFLUORdT/-G TGA
CAA TCT TAG CTG CCG ATA GAG TAG TC-3 . The three-
strand DNA system consisted of a probe sequence 5 -TCA
TTCACACAC-/iFLUORdT/-CG/3BIOTIN/-3  labeledwith
an internal ﬂuorescein dT and biotin, receptor sequence 5 -
/RSSR/GTCTTGTCT CCT GTC AGC TA-3  with a disulﬁde
modiﬁer, a 35-base unmodiﬁed target sequence 5 -CGA
GTG TGT GAA TGA TAG CTG ACA GGA GAC AAG AC-
3 , and a 35-base unmodiﬁed nontarget control sequence 5 -
GTC TAA GAG TGT CCT GGC TAT GAT CCG TGA GTA
TG-3 . The lyophilized DNA was buﬀer-exchanged using an
NAP-V size exclusion column (GE Healthcare) equilibrated
with 20mM sodium phosphate buﬀer, 50mM NaCl pH 7.0.
The receptor DNA (disulﬁde not previously reduced)
was incubated on top of the device in the form of a
50µL droplet at a DNA concentration of 9µMf o r6h r si n
an enclosed incubation chamber. The incubation chamber
also contains a supersaturated NaCl solution to maintain
constant humidity within the enclosed chamber. The device
was immersed in 5mL of 18.2MΩ-cm nanopure H2O
(Barnstead) containing 0.1% Tween-20 (v/v), twice in 5mL
of18.2MΩ-cmnanopureH2OtorinseandremoveunboundJournal of Biomedicine and Biotechnology 3
DNA, and dried under a constant stream of nitrogen gas.
The reporter DNA was bioconjugated to the SPM nanobead
(350nm mean size, Bangs Laboratories) through a biotin-
streptavidin linkage at 30◦C for 1hr. The DNA-nanobead
conjugate was puriﬁed away from free DNA using magnetic
separation and washing the sample 5 times with 20mM
sodium phosphate buﬀer, 300mM NaCl, pH 7.0. The three-
strand DNA strategy included a preconjugation step of the
target DNA to the probe DNA-SPM conjugate at 80◦Ca n d
was allowed to slowly cool to room temperature over 1hr.
Unbound nucleic acid was removed by magnetic separation.
The hybridization assay was carried out by incubating a
25µL droplet of target biotinylated DNA (7µM) bound
to streptavidin-coated SPM beads for 2hrs in an enclosed
incubation chamber containing a super saturated NaCl
solution. The device was washed once in 5mL of 20mM
sodium phosphate buﬀer with 300mM NaCl at pH 7.0
containing 0.1% Tween-20 (v/v), twice in 5mL of 20mM
sodium phosphate buﬀer with 300mM NaCl at pH 7.0,
stored in 20mM phosphate buﬀer with 300mM NaCl at pH
7.0, and protected from ambient light.
2.3.Microscopy. Fluorescencemicroscopywascarriedouton
an inverted Nikon TE2000-E2 Eclipse microscope (Nikon
Instruments Inc.) equipped with a Nikon CFI Plan Apoc-
hromat 40x objective (NA 0.95, 0.14mm WD). Wide-
ﬁeld imaging of the substrates utilized an EXFO E-Cite
illumination source and a FITC ﬁlter (Chroma, ex: 480/30,
DCLP: 505, em: 535/40). Images were acquired on a Pho-
tometrics Coolsnap HQ2 CCD camera. Bright-ﬁeld overlays
utilized diﬀerential interference contrast (DIC) to observe
the diﬀerences in the index of refraction of the samples.
The data were analyzed using Nikon NIS Elements software.
Scanning electron microscopy (SEM) was carried out on a
FEI Nova 400 Nano SEM and utilizing a through-the-lens
(TLD) detector. The SEM images were acquired using a 32-
scan average.
2.4. Hall Measurement. The detection of preimmobilized
SPM beads was achieved by employing an ac phase-sensitive
technique as previously reported [45] .T h eH a l ld e v i c ew a s
b i a s e dw i t had cc u r r e n tI = 50µA, and the beads were
magnetized with an ac magnetic ﬁeld; lock-in detection of
the ac Hall voltage occurred at the magnetic ﬁeld frequency.
The application of an additional dc magnetic ﬁeld reduced
the SPM bead susceptibility and thus the ac magnetic ﬁeld
generated by the beads. This produced a drop in the ac Hall
voltage signal indicating the presence of the beads.
3. Results andDiscussion
3.1. Design. A schematic of the Hall magnetometer-based
biosensor and detection strategy used for detection of a
single-stranded DNA (ssDNA) target sequence by three-
strand annealing over the surface of a 1µm2 Hall junction
is shown in Figure 1. The biosensor platform is assembled
in parallel steps to limit the processing time for target
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Figure 1: Generalized schematic for the detection of label-free
target DNA using Hall magnetometry. The label-free target DNA
(black) is detected by immobilization at the Hall device via comple-
mentary base pairing with receptor DNA (blue) preassembled on
the Hall device surface to additional complementary probe DNA
(red) with an internal ﬂuorescent marker preconjugated to the
surface of a magnetic nanobead resulting in a detectable Hall signal.
Nanobead is not drawn to scale.
detection. This parallels work by others to detect three-
strandannealingusingdiﬀerentsensormodalities,SERS[29]
and colorimetry-(gold plasmon shift) based technologies,
by simultaneously annealing the target, sensor, and probe
sequences [14, 26–28]. Our platform is composed of six
1µm2 Hall junctions (Figure 2(a)) etched into an epitaxially
grown, vertically integrated InAs quantum well heterostruc-
ture isolated from the surrounding environment by a 60nm
overlayer of silicon dioxide, as previously described [42, 44].
The six available Hall junctions are divided into a set of three
bioactive sensors (i, ii, and iii) and three nonactive controls
(ic, iic, and iiic). The bioactive sensors are generated via
patterning3µmgoldbondingpadsevaporatedontotheSiO2
layer only over the bioactive junctions (i, ii, iii). The bonding
pads provide a site for self-assembly of the receptor single-
strand DNA onto the surface of the Hall junction sensor
without modifying the properties of the InAs quantum well
heterostructures. The nonactive controls do not have the
gold bonding pad. To minimize biofouling of the device
by the biological constituents in the sample via nonspeciﬁc
interactions, the exposed SiO2 surface is selectively modiﬁed
by a polyethylene-glycol-conjugated silane moiety [49]. The
bioactive junctions are modiﬁed by self-assembly of the4 Journal of Biomedicine and Biotechnology
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Figure 2: (a) Optical microscopy characterization (wide-ﬁeld ﬂuorescence and DIC overlay) of three-strand DNA assembly is shown by the
presence of green ﬂuorescence indicating the presence of probe DNA. (b) SEM was used to evaluate the location and to quantify the number
of nanobeads contributing to the Hall response for (iii), where the grey box designates the location of the underlying Hall junction. (c) Hall
responses for three active junctions (i, ii, iii) and a single control junction (iiic) are plotted as Hall voltage oﬀset versus time; the presence
of nanobeads over the active Hall junctions results in a drop in Hall voltage when a dc magnetic ﬁeld is applied. (d) The theoretical device
signal stemming from a single 344nm SPM bead is shown to the right as a function of position over the Hall junction further illustrating the
local sensitivity of Hall magnetometry. Scale bars = 2µmi n( a )a n d( b ) .
receptor ssDNA (blue in Figure 1) onto the gold pads by
exposure of a solution of the receptor to the Hall junction
platform (Figure 1(I)) and subsequent washing to remove
unbound DNA. The ﬂuorescein-labeled probe ssDNA
sequence (red in Figure 1)i sp r e a p p e n d e dt ot h eS P Mb e a d
platform via streptavidin-biotin conjugation (Figure 1-(II)).
Prior to the detection of the target DNA sequence (black
in Figure 1), the probe strand and the target strand were
prehybridized (Figure 1-(III)). The detection of the target
DNA was then accomplished by annealing the SPM bead-
probe-target complex with the receptor sequence (blue)
preassembled at the surface of the Hall device platform
at room temperature (Figure 1-(IV)). The assembly of the
three-strand sequence requires 3hrs, which is equivalent to
standard FRET, plasmonic, GMR and SERS-based detection
scenarios, but far faster than optical chip techniques that
can require 16–24hrs to achieve hybridization. Although the
simultaneous addition of all three ssDNA components is
experimentally feasible, stepwise assembly allowed the added
beneﬁt that the observed signal is not artiﬁcially enhanced
by nonspeciﬁc, non-DNA bound SPM beads. All unbound
nucleic acid species and nucleic acid-labeled SPM beads are
removed by magnetic separation prior to ﬁnal three-strand
DNA assembly and washed prior to Hall detection. The
strategy allows a speciﬁc binding event at the electrically
isolated gold pad to induce a direct voltage response in
the device without altering the device properties directly, as
would be observed in SPR-based devices. The sequential,
parallel assembly strategy (Figure 1(I)–(IV)) allows conve-
nient concentration ampliﬁcation for the target ssDNA from
extraneous DNA fragments.
3.2. Detection. In Figure 2 the detection of the 35-base
target on the dual optical/Hall device senor is shown for a
25µL droplet containing 7µM DNA. The speciﬁcity of the
assembly of the three-strand DNA complex onto the gold
pad (grey circle) over the Hall junction is clearly observed
in the wide-ﬁeld ﬂuorescence overlaid with diﬀerential
interference contrast (DIC) micrograph (Figure 2(a)). The
observedgreenphotoluminescenceinFigure 2(a)arisesfrom
the ﬂuorescein label on the probe strand and requires the
three-strand annealing process to occur in order for theJournal of Biomedicine and Biotechnology 5
probe to be optically detectable. The lack of nonspeciﬁc
binding of the probe to regions outside of the gold pad
region conﬁrms the speciﬁcity of the three-strand assembly
protocol. The speciﬁcity of the assembly on the gold pads
is further con-ﬁrmed by comparing the optical micrograph
(Figure 2(a)) and a scanning electron micrograph of the
same region (Figure 2(b); see Figure S1 in Supplementary
Material available online at doi:10.1155/2012/492730). Scan-
ning election microscopy (SEM) imaging of junction (iii)
indicates that ∼73 beads are present on the 3µm (diameter)
gold pad. Inspection of the DIC image of junction (iii)
(Figure 2(a))revealstheregistrybetweentheunderlyingHall
junction in the SEM image (Figure 2(b), grey box), and the
gold pad on the surface of the Hall magnetometer results in
only ∼12 na-nobeads being positioned directly or partially
over the active area of the Hall junction.
FordetectionofDNAannealing,thepresenceoftheSPM
bead is measured as a change in voltage by the use of both ac
anddcmagneticﬁelds.Theuseofbothacanddcﬁeldsallows
for a binding event signal to be cleanly isolated by using
lock-in detection. In the absence of the external dc ﬁeld, no
signal is detectable in the Hall junction. The ac magnetic
ﬁeld of 3.76mT at 93Hz is used to induce magnetization of
the SPM nanobeads. The 70.6mT dc magnetic ﬁeld (NdFeB)
is applied perpendicular to the Hall junction to shift the
magnetization of the nanobeads to lower susceptibility as
givenbytheexpressionΔVH ∝ ΔM,wher eΔM isthechange
in the ac magnetization before and after the dc ﬁeld was
applied. The Hall sensor was operated in constant current
mode with an applied dc current of 50µA.
The voltage responses to binding of the target sequence
with the preappended probe and 350nm magnetic beads
to receptor strands on the three active junctions (i, ii, iii),
plus one control junction without any beads (iiic) are shown
in Figure 2(c). The voltage response for all junctions and
controls are shown in Figure S1. The voltage across the
control junction (iiic) is 0 ± 0.03µV. The successful assembly
of ssDNA over the active Hall junctions results in a sharp
drop in the measured Hall voltage for all three active sensor
elements when a dc ﬁeld was applied. The Hall voltage
measurements are 0.79µV (signal/noise (S/N) 40), 0.55µV
(S/N 28), and 0.78µV (S/N 39), for (i, ii, iii), respectively.
In Figure 2, the observed step function is generated by the
application and removal of the external dc magnetic ﬁeld in
the presence of the small ac ﬁeld to allow lock-in detection.
The S/N was determined by averaging the change in signal
when the dc ﬁeld was applied and dividing it by the average
standard deviation from zero measured in the absence of the
applied dc ﬁeld. The standard deviation in measured signals
for the active junctions is 0 ± 0.02µV as shown in Figure S1.
To analyze the voltage change per binding event, the
number of beads per Hall junction must be assessed. In
Figure 2(a) and Figure S1, the SEM micrographs indicate
the presence of 41 beads on junction (i), 68 beads on
junction (ii), and 73 beads on junction (iii). In Figure 2(c),
the voltage response for the three pads is similar regardless
of the number of beads bound at the center of the Hall
junction (Figure 2(c)). The largest expected voltage change
in the Hall magnetometer will occur for beads directly
over the Hall junction, falling rapidly for beads positioned
>0.5µm from the device center (Figure 2(d)). Directly over
the Hall junction (shaded region Figure 2(b)), junction
(i) has 8 beads, junction (ii) has 11 beads, and junction
(iii) has 12 beads. Calculation of the predicted voltage
response as a function of the distance of the bead from the
center of the Hall junction is shown in Figure 2(d).F o ra
single 350nm magnetic bead approximately 272nm from
the Hall device, a voltage response of 0.4µVp e rb e a di s
expected. The experimental value of ∼0.6–0.8µVm e a s u r e d
in Figure 2(c) following DNA annealing of the target and
probe indicates that more than one bead but not all of
the bound beads contribute to the measured Hall voltage.
For junction (iii), the result suggests the measured voltage
is likely dominated by the 12 beads directly over the Hall
junction (only beads contained within the grey box in
Figure 2(b)). Due to the large size dispersion and subsequent
large magnetic content variability in the commercially
obtained SPM beads utilized in this study, the calculation
of the number of beads contributing to the measured signal
cannot be obtained if more than one bead lies directly
over the underlying Hall junction. Based on the theoretical
voltage (Figure 2(d)) and the observed voltage in response
to DNA annealing (Figure 2(c)), a single bead should be
detectable.
3.3. Single-Bead Detection. Although magnetic transduction
devices are remarkably sensitive with detection of a single
bead (<500nm) reported for an antibody-antigen sandwich-
assay-based assembly of a magnetic bead on a micron-sized
Hall device [44], and the multiple-bead detection by GMR
devices [36], the report of three-stand DNA target detection
at the single-magnetic-bead level by a Hall device has not
been reported to date. Single-bead detection was observed
for a 35-base pair DNA annealing event onto a Hall device,
asshowninFigure 3.TheHallvoltageresponse(Figure 3(b))
and corresponding SEM image (Figure 3(c)) for the two-
strandannealingevent(Figure 3(a))indicateavoltageof0.34
± 0.03µV( 0± 0.04µV for control junction) for the two
observed beads near the Hall junction. The two-dimensional
(2D) theoretical Hall response has recently been modeled
with respect to SPM bead position over the Hall junction
[50]. The theoretical response for a single bead over the
Hall junction in Figure 3 is shown in Figure 3(d),w h e r e
red indicates a SPM particle positioned at the center of the
device,whileblueisaSPMoutsidethedetectablerangeofthe
Hall junction. The measured voltage in Figure 3 is consistent
with the theoretical value for a single bead, and therefore it
is believed that the measured Hall voltage reﬂects only one
of the two beads, since only one of the beads lies within
the red zone for the theoretical plot (arrow in Figure 3(c)).
Improvement of the signal-to-noise ratio can be achieved by
operating the Hall device at higher frequencies; however, it is
importanttonotethatthesensitivityofthedevicecanclearly
distinguish a single-bead binding event from the noise ﬂoor
by an order of magnitude at the frequency utilized in this
study.6 Journal of Biomedicine and Biotechnology
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Figure 3: Sequence-speciﬁc two-strand DNA assembly and subsequent Hall detection of a single 344nm nanobead. (a) Pictorial
representation of two-strand DNA assembly, where the probe DNA (red) is complementary to the receptor DNA (blue). (b) Hall response
data for the active (iv) and control Hall junction (ivc) plotted as Hall voltage versus time, where the drop in Hall voltage corresponds to the
presence of a magnetic nanobead. (c) SEM was used to conﬁrm that only one nanobead contributed signiﬁcantly to the signal measured
in (iv); scale bar = 2µm. (d) The theoretical Hall device cross-sectional response for a single 344nm SPM bead as a function of position
from the center of the junction, where red indicates strongest change in voltage, aqua indicates weakest voltage change, and blue indicates a
negative voltage readout. The noise ﬂoor for the device is outlined in black for reference.
3.4. Selectivity and Detection Limits. The limit of detection
for DNA in a real sample will reﬂect the length and sequence
of target DNA (both of which inﬂuence annealing tempera-
ture), and the concentration of DNA, and the concentration
of DNA present in a milieu of nontarget DNA. Since
sensitivity will be inﬂuenced by bead size and the area of the
transduction platform, the concentration limit of detection
for target DNA was assessed using optical microscopy
analysis of the binding of the target DNA onto 2 × 4µmg o l d
patterns that serve as mimics of the GaAs Hall devices.
The thermodynamic stability of the three-strand DNA
approach has been used for several sensor approaches,
including optical, SERS, and colorimetric platforms. In the
current study the stability of the three strands was experi-
mentallyveriﬁedusingagelshiftassay(FigureS3).InFigures
4(a) and 4(b), binding of the 35-base pair three-strand DNAJournal of Biomedicine and Biotechnology 7
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Figure 4: Three-strand DNA assembly on a mimic array (patterned on a GaAs substrate) for (a) complementary target only and (c) 10ppm
target in nontarget DNA. The inlays in the lower left of (a) and (c) are an enlarged portion of (a) and (c), respectively. Scale bars = 50µm.
(b) A line scan of the wide-ﬁeld ﬂuorescence microscopy image in (a) showing ﬂuorescein-labeled probe DNA (green) and DIC (black)
intensity correlates ﬂuorescence intensity with nanobeads located primarily over gold pads, where the black arrows signify the presence of a
small number of nonspeciﬁcally bound nanobeads.
assembly onto a mimic was assessed by the ﬂuorescently
labeled probe sequence conjugated to the 350nm magnetic
beads. Inspection of a line scan for the ﬂuorescence intensity
from the probe sequence shows good correlation with the
Hall mimic patterns (Figure 4(b)). The signal ﬂuctuations
do not indicate single-bead response as the ﬂuorescein
intensity depends on the particle size, number of DNA probe
strands,labelingeﬃciency,andfocalplaneofthemicroscopy
image. Little intensity is observed over the control PEGy-
lated regions surrounding gold pads (identiﬁed with black
arrows). The discrimination level is >10,000 counts above
backgroundforselectivetargetDNAbindingatthegoldpads
in buﬀered solution (Figure 4(a) and Figure S2).
An important measure of device performance is the abil-
ity to discriminate target ssDNA in the presence of extrane-
ous (noncomplementary) sequences in solution, particularly
at low levels of target DNA. The ability to discriminate target
DNA in the presence of nontarget sequences was analyzed
by optical microscopy on 3µmp a t t e r n e dG a A sH a l ld e v i c e
mimics in a buﬀered solution. Since the sensitivity of the
device was demonstrated to achieve a limit of detection that
is consistent with a single bead (0.34µVv e r s u s0± 0.04µV
noise ﬂoor), the choice of an optical mimic to only probe
ﬁdelity over a Hall junction allows analysis of the limit of
detection for the three-strand annealing process. Fluores-
cently tagged nanobeads were selectively annealed at gold
pads at a concentration of 364pM target DNA in a solution
containing 36µM nontarget DNA, which corresponds to less
than two complementary target DNA sequences per 350nm
nanobead (Figure 4(c)). The measurements equate to detec-
tion at the 10ppm level target. For comparison, a mimic
arrayinwhichthereceptorstrandwasnoncomplementaryto
the target strand clearly demonstrated that nonspeciﬁc DNA
binding is not observed (Figure S2). Although we have not
yet tested cellular extracts of nucleic acids, the sensitivity and
selectivity of the device—detection of a single SPM bead at a
Hall junction, corresponding to 1-2 target DNA molecules—
clearly demonstrate for the ﬁrst time that this technology
holds substantial promise for biomoleculesensing.
4. Conclusion
The device strategy utilizing three-strand DNA assembly
on a Hall magnetometer provides a detection platform with
high speciﬁcity, low limit of detection (single SPM bead,
and small numbers of target DNA molecules), and very high
ﬁdelity. Sensitivity of the Hall biosensor is attributable to the
properties of the Hall junction and is dependent on the size
of the Hall junction, the frequency of the ac ﬁeld oscillation,
the moment of the SPM bead, and the distance of the SPM
bead from the Hall junction. In the nanotechnology device,8 Journal of Biomedicine and Biotechnology
the use of a SPM nanobead does not hinder the speciﬁcity
of Watson-Crick base pairing for the target nucleic acid as
evidenced by sequence-speciﬁc DNA hybridization (Figure 2
and Figure S2). At the detection frequency employed in this
study, the 3D plot in Figure 3(d) indicates the possibility
of detecting an SPM bead at distances approaching 0.9µm
oﬀ the surface of the device when the SPM bead is located
directly over the center of the Hall junction, which may
allow much longer sequences of DNA to be detected.
Higher frequency measurements will decrease the noise level
and therefore increase the sensitivity of the device to the
magnetic bead position.
We have demonstrated the successful use of Hall mag-
netometry to detect a 35-base target DNA at the single-
magnetic-bead level that could be applied for POC diag-
nostics. Reduction of the dimension of the gold pad and
improv edregistry ,aswellasbeadhomogeneitycouldbeused
to further improve upon the overall device performance.
Extrapolation of the device to a microarray of selectively
labeled Hall sensors could represent a transformative biosen-
sor platform. The parallel Hall device strategy could allow
multiple DNA sequences to be simultaneously detected in
a biological matrix since each magnetic bead and probe
strand can be bar-coded by dye photoluminescence [23]a n d
SPM bead size since the response will be proportional to the
SPM moment. Alternatively, the receptor DNA on the Hall
junction can be selectively dip-penned for multisequence
analysis[51].Byeliminatingconcernsassociatedwithsample
ampliﬁcation [3] such an array would allow screening for
nucleic acid targets of biomedical interest such as pathogens
or disease-related mutations [52–56].
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